Is IL2RG oncogenic in T-cell development?

Journal Article (2006)
Author(s)

K Pike-Overzet (External organisation)

D De Ridder (TU Delft - Multimedia Computing)

F Weerkamp (External organisation)

MRM Baert (External organisation)

MM Verstegen (External organisation)

MH Brugman (External organisation)

SJ Howes (External organisation)

Marcel Reinders (TU Delft - Multimedia Computing)

AJ Thrashers (External organisation)

G Wagemaker (External organisation)

JJM van Dongen (External organisation)

FJT Staal (External organisation)

Multimedia Computing
More Info
expand_more
Publication Year
2006
Multimedia Computing
Issue number
7109
Volume number
443

Abstract

The gene IL2RG encodes the -chain of the interleukin-2 receptor and is mutated in patients with X-linked severe combined immune deficiency (X-SCID). Woods et al.1 report the development of thymus tumours in a mouse model of X-SCID after correction by lentiviral overexpression of IL2RG and claim that these were caused by IL2RG itself. Here we find that retroviral overexpression of IL2RG in human CD34+ cells has no effect on T-cell development, whereas overexpression of the T-cell acute lymphoblastic leukaemia (T-ALL) oncogene LMO2 leads to severe abnormalities. Retroviral expression of IL2RG may therefore not be directly oncogenic ¿ rather, the restoration of normal signalling by the interleukin-7 receptor to X-SCID precursor cells allows progression of T-cell development to stages that are permissive for the pro-leukaemic effects of ectopic LMO2.

No files available

Metadata only record. There are no files for this record.